NORD Rare Diseases + Orphan Products Breakthrough Summit
From 15 to 17 October 2023
At : Washington DC, USA
From 15 to 17 October 2023
At : Washington DC, USA
From 21 to 22 October 2023
At : Kyoto, Japan
From 01 to 05 November 2023
At : Washington DC, USA
From 07 to 08 November 2023
At : Paris, France
From 08 to 10 November 2023
At : Rotterdam, Netherlands
From 20 to 21 November 2023
At : Amsterdam, Netherlands
From 14 to 17 February 2024
At : Johannesburg, South Africa
From 23 to 24 April 2024
At : Milan, Italy
From 15 to 17 May 2024
At : Brussels, Belgium (hybrid)
From 07 to 08 June 2024
At : Los Angeles, USA
On 08 June 2024
At : Los Angeles, USA
From 12 to 14 June 2024
At : Paris, France
The French Foundation for Rare Diseases has announced the opening of a new facilitation window of the MOOC From Lab to Clinic: Translational Research for Rare Diseases on October 9th. This update will be available until December 2nd 2023.
In this course, you'll get to learn from experts about how medicines are developed, tested in clinical trials, approved by regulators, and the unique challenges of working with rare diseases. You'll also hear from both patients and experts in the field, which will give you valuable perspectives. You'll learn about how clinical trials are planned, designed, and how data is shared. By the end of the course, you'll have a good understanding of how we gather evidence to make sure treatments for rare diseases are safe and effective.


The National Organization for Rare Disorders has a number of accredited continuing medical education courses on rare cancers available online. These courses are intended for healthcare providers currently practicing in the United States, and feature top medical specialists, NORD member advocacy organisations, rare disease patients, and Centres of Excellence. The courses are provided in partnership with Platform Q Health, and are available for CME credit for one year following their publication.
The European Reference Networks often organise educational webinars and other online meetings for their members and/or other interested parties. Below is a list of some upcoming events that may be of interest to our readers:


The EJP-RD is holding workshops aiming at training ERN researchers and clinicians in relevant innovative themes with a cross-ERN added value. These 2-days ERN workshops are open to interested persons (clinicians/scientists) affiliated to ERNs or Affiliated Partner Institutions.
Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation, etc. Topics have to be proposed by the ERNs or by investigators belonging to EJP RD beneficiary institutions. Registrations are now open for several workshops.
Throughout the year, the Recordati Foundation is organising a series of courses to help advance knowledge in rare diseases. The programme contains the following sessions:
For more information about the content of the courses and details about registration, please visit the Foundation's website.
On 28 September 2023
At : Online

Rare Disease Project ECHO is a component of the RArEST project, seeking to strengthen clinical learning practice for rare diseases. Regular videoconferencing sessions connect community providers with a multidisciplinary team of experts, who are able to equip communities with timely, necessary knowledge.
The next session will take place on 28 September 2023, focused on supporting family members of people living with a rare disease. Visit the link below for more information on how to register and get involved.
From 29 to 30 September 2023
At : Paris, France
From 29-30 September 2023, the European Society for Medical Oncology (ESMO) will be hosting a course on the prevention, diagnosis, treatment, and management of hereditary cancers. It is aimed at oncologists residing in Europe, but is open to all ESMO members. For successful applicants, there is no cost to apply and accommodation will be provided. A travel grant of up to 400 EUR is also available to help cover travel costs. Applications for the course will close on 27 June 2023.
From 12 to 13 October 2023
At : Nijmegen, Netherlands

The EJP RD is organising a workshop on "CDH1 related hereditary diffuse type gastric cancer: The shift from prophylactic total gastrectomy to optimal endoscopic surveillance" as part of their series of ERN workshops. This workshop is open to the entire ERN community, as well as PhD students, researchers, and clinicians interested in the field of hereditary diffuse type gastric cancer. Registration is open until 15 July, 2023.
From 13 to 14 October 2023
At : Rome, Italy

From 13-14 October 2023, the EJP RD will be organising an ERN workshop on "Advances in regenerative medicine and tissue engineering for rare musculo-skeletal diseases." The workshop aims to improve the knowledge and competences on up-to-date regenerative medicine and tissue engineering technologies exploited in the design of advanced therapies for rare diseases affecting skeletal muscles and bones, and is open to the entire ERN community.
From 18 to 20 October 2023
At : Warsaw, Poland

The 5th International Training Course on "Quality assurance, variant interpretation and data management in the NGS diagnostic era" will be organised from 18-20 October 2023 in the framework of the EJP RD. The main goal of the course is to keep researchers and clinicians up to date on the latest techniques and practices related to next-generation sequencing (NGS) and variant interpretation. It is open to participants from the international research community, including clinicians, specialists, policy makers, and patient representatives (among others) with a basic knowledge in biology or medicine. The deadline to register is June 20th, 2023.

Registration is now open for the 2024 edition of EURORDIS' Open Academy Schools, taking place in June 2024 in Barcelona. Taking place over one week, the Open Academy School on Medicines Research & Development (formerly EURORDIS Summer School) and the Open Academy School on Scientific Innovation & Translational Research (formerly EURORDIS Winter School) will run in parallel, providing patient advocates and PhD researchers with the chance to gain rare disease-specific, comprehensive training programs. Participants of both schools will follow a program including off-site visits to research facilities/hospitals, contact time with faculty and EURORDIS staff, and plenty of networking opportunities.
Applications for both schools closes on 27 October 2023. For more information on the specific application criteria and procedure for each school, visit the EURORDIS Open Academy website.

On 26 October 2023
At : Online

Rare Disease Project ECHO is a component of the RArEST project, seeking to strengthen clinical learning practice for rare diseases. Regular videoconferencing sessions connect community providers with a multidisciplinary team of experts, who are able to equip communities with timely, necessary knowledge.
The next session will take place on 26 October 2023, focused on care coordination and connection. Visit the link below for more information on how to register and get involved.
On 23 November 2023
At : Online

Rare Disease Project ECHO is a component of the RArEST project, seeking to strengthen clinical learning practice for rare diseases. Regular videoconferencing sessions connect community providers with a multidisciplinary team of experts, who are able to equip communities with timely, necessary knowledge.
The next session will take place on 23 November 2023, focused on Whole of Life Care. Visit the link below for more information on how to register and get involved.
From 07 to 08 December 2023
At : Strasbourg, France

The ERN-EYE will be holding their next workshop from 7-8 December 2023 in Strasbourg, France on "Rare eye diseases: challenges and dilemmas in the era of genomics and personalised medicine."


The European Reference Network for Rare Neurological Diseases (ERN-RND) organises joint free educational webinars on rare neurological and movement disorders with EAN. These 1-hour webinars take place throughout the year and are presented by international experts. They discuss various aspects from more general clinical features, examination, disease diagnosis, medical interventions, and disease management to more specific ones as use of scales or imaging. Adult and paediatric neurology are both covered.
Further information about ERN-RND webinars in collaboration with EURO-NMD and the European Academy of Neurology (EAN) is available here.
From 07 to 08 December 2023
At : Barcelona, Spain
The TREAT-NMD network will be holding an expert masterclass on Becker muscular dystrophy from 7-8 December 2023 in Barcelona, Spain. This in-person event is aimed at healthcare professionals and researchers who are or will become involved in the diagnosis, care, and treatment of patients with BMD in Europe.
From 13 to 14 December 2023
At : Milan, Italy

The EJP-RD is offering a training workshop from 13-14 December 2023 on how to manage rare disease biological sample data in biobanks. Aimed at biomedical researchers, medical professionals, and biobank managers who want to develop the capacity on data mangement of biobanks, the workshop will explore the high value of biological sample repositories for rare disease research. Registration is open to healthcare professionals, researchers, clinicians, biobank managers, database managers, and patient advocates. Travel fellowships are available. Prospective participatns are asked to apply by 23rd October 2023.
On 18 December 2023
At : Barcelona, Spain (hybrid)

On 18 December 2023, a hybrid workshop on immune dysregulation is being organised by members of the ERN RITA in collaboration with the University Hospital Sant Joan de Déu in Barcelona. Participation is free, and all interested parties are invited to attend.

The National Organization for Rare Disorders has announced the following new funding opportunities:
More information about the specific calls is available on NORD's website.
The Europan Health and Digital Executive Agency (HaDEA) has published 12 calls for proposals under the 2023 EU4Health Work Programme. The topics cover a range of different health-related subjects. In particular, topic PJ-11 is for a program on orphan medical devices, in particular targeting paediatric patients. The total budget for the calls is €19,960,000. The deadline for applications is on 17 October 2023, 17h00 CET.
Applications are now open for the EveryLife Foundation's 2024 Rare Giving grant. This program is intended to support organisations that engage patients, caregivers, and other members of the rare disease community in advocacy and public policy in order, in order to ensure policymakers and regulators hear their voices directly. Three types of funding are available for eligible 501(3)c non-profit organisations:
Applications for all Rare Giving 2024 grants must be submitted by 27th October 2023. Any questions can be directed to klaws@everylifefoundation.org.
The IQSEC2 Research and Advocacy Foundation is offering a 1-year grant to support research related to IQSEC2-related disorder. The Foundation will award either one grant of $60,000 or two grants of $30,000. All individuals holding a faculty-level position or a senior position at a non-profit institution or foundation are eligible to apply, including researchers with no prior experience with IQSEC2. Applications must be submitted by 4 November 2023.
The Canadian Institutes of Health Research has announced several new funding opportunities for rare disease projects. The first team grant, "Improving Diagnosis for Rare Disease Patients," aims to support research which will determine the best pathway to diagnose RDs by moving genomic testing towards the front end of the care pathway. The maximum amount per grant is $458,333 per year for up to 3 years. The submission deadline is 7 November 2023.
The second opportunity, "Improving Health and Administrative Data and Monitoring for Rare Diseases," aims to support implementation research to determine the prevalence, direct cost, and burden of rare diseases in the Canadian health care systems. The maximum amount per grant is $400,000 per year over four years. The submission deadline is 7 November 2023.

The European Commission's Horizon Europe Health Calls 2023 are now open, with several funding calls specific to rare diseases:
The topic "Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases" is part of the Innovative Health Initiative JU Call 4. It is a two-stage call, with an initial submission deadline of 8 November 2023 at 17:00 CET.
The 2023 edition of Medics for Rare Diseases' Student Voice Prize is now open for applications. This international essay competition offers applicants the chance to have their work published in the Orphanet Journal of Rare Diseases, to present at M4RD's annual conference in London, and to receive cash prizes. It is open to all students of medicine, nursing, and biological sciences. The submission deadline is 15th November 2023 at 12pm GMT. More information on the submission and eligibility criteria is available here.
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) has announced a grant to support efficient and innovative natural history studies that advance medical product development in rare diseases with unmet needs. The funding opportunity announcement is entitled “Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required”. The purpose of this grant is to address critical knowledge gaps and facilitate rare disease product development. The receipt dates for this funding opportunity are 15 February 2022 and 13 February 2024.
Another funding opportunity from the OOPD is available for fiscal years 2023-2025 to support clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. The grant is titled "Clinical studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)." The receipt dates for this opportunity are 24 October 2023 and 22 October 2024.
LaunchBio is a nonprofit organisation in Silicon Valley which holds small conferences to connect rare disease biotech entrepreneurs and investors. Fondation Ipsen is offering three travel scholarships to European rare disease entrepreneurs who would like to attend a LaunchBio event to promote their company. The scholarship covers the cost of a flight, plus three nights of hotel accommodations. Interested applicants are invited to send the name of their company, the LaunchBio event they would like to attend, as well as 150-300 words explaining how they would benefit from a Fondation Ipsen Schloarship to Clea Stemitsiotis at clea.stemitsiotis@ipsen.com. The program is open until all scholarships have been used.
![]()
Orphanet is looking to hire a Scientific monitoring and content acquisition officer. The job listing is available here.
If interested, please send your CV and cover letter to jobs.orphanet@inserm.fr.
![]()
Orphanet is looking to hire a Document Resource Manager, Genes and rare disease nomenclature. The job listing is available here.
If interested, please send your CV and cover letter to jobs.orphanet@inserm.fr.

EURORDIS is looking to fill multiple positions, including Compliance & Budget Manager, Chief Executive Officer, Corporate and Donor Relations Assistant, and Communications Junior Manager, Projects & Programmes. More information is available here.

The latest episode of Rare on Air, EURORDIS's podcast dedicated to rare diseases, is out now. In this episode, host Julien Poulain dives into the world of newborn screening, speaking about the importance of early diagnosis for rare diseases and the findings from the latest Rare Barometer survey.
In a new video as part of FTI Consulting's series "Game Changers in Health," Senior Orphan Drug Pharmacist Mark Dooms unpacks the new EU pharmaceutical legislation and discusses the change it represents in Europe's approach to rare diseases, the benefit it may bring to the rare disease community, and what still remains to be done.